Section VI：Probiotics,Prebiotics and Postbiotics - Session 6：Microbiome Balance and Host Health:From Mechanisms to Applications

2027-02-25 09:00-11:40

2027-02-25 09:00-09:20

Next-Generation Probiotic Screening Strategies and R&D Pathways Targeting Immune Regulation

He Fang Professor West China School of Public health of Sichuan University (West China Fourth Hospital)

2027-02-25 09:20-09:40

Dietary Live Microorganism Intake Status and Health Associations Among Chinese Residents

Xiang XueSong Research Fellow Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention

2027-02-25 09:40-10:00

Gut-Musculoskeletal Axis:New Opportunities for Probiotics in Bone,Joint,and Mobility Health

Mary Farrell Scientific Affairs Manager ，Probi

2027-02-25 10:00-10:20

Scientific Evidence of Probiotic Lactobacillus casei Strain Shirota (LcS)

Yakult

2027-02-25 10:20-10:40

From Lab to Clinic:The Systematic Scientific Evidence Journey of Lacticaseibacillus rhamnosus CRL1505

Sacco System,Italy

2027-02-25 10:40-11:00

Multimodal Digital Approaches in Microbiome Research:From Baseline Stratification to Intervention Trial Evaluation

Xingyu Wang Scientific Research Supervisor of Scientific Development Department DiPROBIO (Shanghai) Co.,Limited

2027-02-25 11:00-11:20

Mechanistic Foundations and Clinical Evidence of Liposomal Bupivacaine

Chen Yun Senior Scientist,STA,GC,dsm-firmenich

2027-02-25 11:20-11:40

ADM Enabling New Postbiotic Opportunities:Cutting-Edge Postbiotic Solutions from a White Paper Perspective

Section VI：Probiotics,Prebiotics and Postbiotics - Session 8：Next-Generation Probiotics:Akkermansia muciniphila (AKK)

2027-02-25 13:30-15:50

2027-02-25 13:30-13:50

Domestic and International Research Progress and Industrialization Status of Akkermansia muciniphila (AKK)

Lu Wenwei,Vice Dean,School of Food Science and Technology,Jiangnan University

2027-02-25 13:50-14:10

Research Progress on AKK Safety:A Systematic Review Based on Preclinical and Clinical Evidence

China National Center for Food Safety Risk Assessment

2027-02-25 14:10-14:30

Next-Generation Probiotic:Development and Application of Akkermansia muciniphila Akk11 in Metabolic Health Regulation

Liu Litai,R&D Manager,Weikan Probiotics (Suzhou) Co.,Ltd.

2027-02-25 14:30-14:50

Akkermansia muciniphila MucT®:How a scientific discovery becomes a leading innovation?

Dr Anneleen Segers,Senior Scientist,The Akkermansia Company (part of Danone Group)

2027-02-25 14:50-15:10

Mechanistic Study of AKK ONE Strain in Improving Enteritis and Cognitive Function

Li Nan,R&D Director,Sirio Pharma (China) Co.,Ltd.

2027-02-25 15:10-15:30

Clinical Study of AKK Intervention in Obese,Overweight,and PCOS Populations

Prof. Chen Tingtao,Nanchang University

2027-02-25 15:30-15:50

Agenda